ALPINE IMMUNE SCIENCES, INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2024.

Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
09 May 2024

Quick Takeaways

  • ALPINE IMMUNE SCIENCES, INC. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2024.
  • Headline metric: Return On Equity -15%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-67%</span>.
  • Most recent SEC facts end date: 09 Apr 2024.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2024-04-09) highlights Return On Equity -14.7%, Return On Assets -11.6%, and Operating Margin -90.9%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

50.6/100

Caution Confidence high

Return On Equity

-15%

Metric score 0.0/100

Return On Assets

-12%

Metric score 0.0/100

Financial Health

Current Ratio
9.56x
Quick Ratio
1.03x
Debt to Equity
0.26x

Strengths

Quick Ratio, Debt-to-equity, and Revenues YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-15%

YoY: -67%

Industry median: -43% (n=675)

View history

Return On Assets

-12%

YoY: -55%

Industry median: -47% (n=673)

View history

Operating Margin

-91%

YoY: -65%

Industry median: -121% (n=298)

View history

Current Ratio

9.56x

YoY: +175%

Industry median: 3.39x (n=667)

View history

Quick Ratio

1.03x

YoY: +287%

Industry median: 1.51x (n=289)

View history

Debt-to-equity

0.26x

YoY: -62%

Industry median: 0.26x (n=530)

View history

Revenues YoY

119%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

42%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -15% -67%
Return On Assets -12% -55%
Operating Margin -91% -65%

Financial Health

Metric Latest value YoY change
Current Ratio 9.56x +175%
Quick Ratio 1.03x +287%
Debt-to-equity 0.26x -62%

Growth

Metric Latest value YoY change
Revenues YoY 119%
NetIncomeLoss YoY 42%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 65,560,484 +37%
Common Stock, Shares, Outstanding 65,552,322 +37%
Weighted Average Number of Shares Outstanding, Basic 64,033,018 +35%
Weighted Average Number of Shares Outstanding, Diluted 64,033,018 +35%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $56,521,000 +119%
Research and Development Expense $83,780,000 +14%
General and Administrative Expense $24,095,000 +30%
Operating Income (Loss) $51,354,000 +23%
Earnings Per Share, Basic -1 +64%
Earnings Per Share, Diluted -1 +64%
Cash and Cash Equivalents, at Carrying Value $33,015,000 +128%
Accounts Receivable, after Allowance for Credit Loss, Current $42,000 -94%
Assets, Current $308,251,000 +55%
Property, Plant and Equipment, Net $1,356,000 -20%
Operating Lease, Right-of-Use Asset $7,317,000 -9.1%
Assets $373,646,000 +43%
Accounts Payable, Current $4,170,000 +151%
Accrued Liabilities, Current $16,891,000 +40%
Contract with Customer, Liability, Current $10,227,000 -75%
Liabilities, Current $32,238,000 -44%
Contract with Customer, Liability, Noncurrent $0 -100%
Operating Lease, Liability, Noncurrent $8,705,000 -11%
Liabilities $40,943,000 -56%
Accumulated Other Comprehensive Income (Loss), Net of Tax $263,000 +35%
Retained Earnings (Accumulated Deficit) $274,063,000 -16%
Stockholders' Equity Attributable to Parent $332,703,000 +96%
Liabilities and Equity $373,646,000 +43%
Share-based Payment Arrangement, Noncash Expense $3,989,000 +56%
Increase (Decrease) in Accounts Receivable $123,000 -144%
Net Cash Provided by (Used in) Operating Activities $27,690,000 -5.9%
Net Cash Provided by (Used in) Financing Activities $19,351,000
Net Cash Provided by (Used in) Investing Activities $2,562,000 -109%
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 65,552,322 +34%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10,905,000 -1101%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33,284,000 +126%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 -100%
Depreciation $147,000 +5%
Payments to Acquire Property, Plant, and Equipment $19,000 -80%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $36,692,000 +42%
Operating Lease, Liability, Current $950,000 +20%
Preferred Stock, Shares Issued 0
Current Income Tax Expense (Benefit) $0
Preferred Stock, Shares Authorized 10,000,000 0%
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $12,067,000 +22%
Interest Expense $28,000 -93%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY